BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

Nicholas Investment Partners, LP's Holding History (CIK: 0001389574)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 1,690,000 Value ($000) $1,666 Avg Close — Range —
Q3 2023
Shares 1,690,000 Value ($000) $1,639 Avg Close — Range —
Q2 2023
Shares 2,940,000 Value ($000) $2,888 Avg Close — Range —
Q1 2023
Shares 2,940,000 Value ($000) $3,016 Avg Close — Range —
Q4 2022
Shares 2,940,000 Value ($000) $3,120 Avg Close — Range —
Q3 2022
Shares 2,940,000 Value ($000) $2,913 Avg Close — Range —
Q2 2022
Shares 2,440,000 Value ($000) $2,416 Avg Close — Range —
Q1 2022
Shares 440,000 Value ($000) $440 Avg Close — Range —
Q4 2021
Shares 8,700,000 Value ($000) $9,097 Avg Close — Range —
Q3 2021
Shares 5,500,000 Value ($000) $5,628 Avg Close — Range —
Q3 2020
Shares 3,330,000 Value ($000) $3,494 Avg Close — Range —
Q2 2020
Shares 3,330,000 Value ($000) $4,069 Avg Close — Range —
Q1 2020
Shares 3,175,000 Value ($000) $3,327 Avg Close — Range —